In the United States, minorities are underrepresented in research studies that help test and develop new treatments for common and serious medical conditions, such as type 2 diabetes and COVID-19. This is despite these same populations facing a high burden of both type 2 diabetes and COVID-19. In fact, black people have one of the highest rates of type 2 diabetes (13.2%), a rate almost twice as high as non-Latino white people (7.6%). We also know that black and Latino people are most affected by COVID-19. To develop new treatments, it is important to make sure that the treatments are safe and effective for racial and ethnic minorities. Previous research tells us that in some cases, less than 5% of participants in research studies were black. This is a problem because certain treatments can affect people of different races or ethnicities in different ways. As a result, researchers must work harder to include more minority participants.
Photo by Rawpixel